Stay updated on Lenvatinib and Pembrolizumab in DTC Clinical Trial

Sign up to get notified when there's something new on the Lenvatinib and Pembrolizumab in DTC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lenvatinib and Pembrolizumab in DTC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.5 to v3.6.6, signaling a new site build or update for the study details page.
    Difference
    0.0%
    Check dated 2026-08-29T23:46:18.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    The page’s revision label was updated to v3.6.5, indicating a new maintenance release of the study page. No study details or content appear to have changed as part of this update.
    Difference
    0.0%
    Check dated 2026-08-08T23:14:16.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.3 to v3.6.4. This represents a minor update to the page's revision history rather than changes to the study details or user-facing content.
    Difference
    0.0%
    Check dated 2026-07-25T12:30:34.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The page revision tag was updated from Revision: v3.6.2 to Revision: v3.6.3, indicating a small housekeeping update to the page's metadata rather than a change to the study details.
    Difference
    0.0%
    Check dated 2026-07-04T03:55:26.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.0 to v3.6.2, signaling a minor maintenance update to the page version without altering study details.
    Difference
    0.0%
    Check dated 2026-06-27T01:23:36.000Z thumbnail image
  9. Check
    83 days ago
    Change Detected
    Summary
    The page's Study Documents section and several blocks listing study locations, investigators, and identifiers have been removed. This reduces visibility of critical trial materials and contact information, affecting the ability to review and engage with the study record.
    Difference
    19%
    Check dated 2026-06-19T23:46:03.000Z thumbnail image

Stay in the know with updates to Lenvatinib and Pembrolizumab in DTC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lenvatinib and Pembrolizumab in DTC Clinical Trial page.